Therapeutic vaccines for chronic infections

Science

Volumn 305, Issue 5681, 2004, Pages 205-208

  Autran, Brigitte ^a   Carcelain, Guislaine ^a   Combadiere, Béhazine ^a   Debre, Patrice ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGY; STRATEGIC PLANNING; VIRUSES;

ANTIMICROBIAL THERAPY; CHRONIC INFECTIONS; THERAPEUTIC VACCINES;

VACCINES;

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS B ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMID DNA; RANTES; VACCINE;

MEDICINE;

CHRONIC DISEASE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VACCINATION; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANTI-HIV AGENTS; CHRONIC DISEASE; CLINICAL TRIALS; COMBINED MODALITY THERAPY; HEPATITIS B; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; T-LYMPHOCYTES; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL VACCINES;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 3042807072     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1100600     Document Type: Review

References (35)

1. P. Debré, Louis Pasteur (Flammarion, Paris, 1995).
2. B. Rocha, C. Tanchot, Curr. Opin. Immunol. 16, 259 (2004).
3. V. Appay et al., Nature Med. 8, 379 (2002).
4. S. Galluci, P. Matzinger, Curr. Opin. Immunol. 13, 114 (2001).
5. F. Triebel, Trends Immunol. 24, 619 (2003).
6. D. H. Barouch et al., Science 290, 486 (2000).
7. S. C. Jameson, Nature Rev. Immunol. 2, 547 (2002).
8. K. Hanazaki, Curr. Drug Targets Inflamm. Allergy 3, 63 (2004).
9. S. Pol et al., J. Hepatol. 34, 917 (2001).
10. K. Yalcin, M. Acar, H. Degertekin, Infection 31, 221 (2003).
11. B. Dikici et al., Pediatr. Infect. Dis. J. 22, 345 (2003).
12. A. Dahmen, S. Herzog-Hauff, W. O. Bocher, P. R. Galle, H. F. Lohr, J. Med. Viroi. 66, 452 (2002).
13. P. Boffeta, D. M. Parkin, Cancer J. Clin. 44, 81 (1994).
14. L. A. Koutsky et al., N. Engl. J. Med. 347, 1645 (2002).
15. E. M. Burd, Clin. Microbiol. Rev. 16, 1 (2003).
16. J. H. Bartholomew et al., Eur. J. Immunol. 24, 3175 (1994).
17. C. J. Lacey et al., J. Infect. Dis. 179, 612 (1999).
18. A. M. Kaufmann et al., Clin. Cancer Res. 8, 3676 (2002).
19. B. Autran et al., Science 277, 112 (1997).
20. D. Finzi et al., Nature Med. 5, 512 (1999).
21. R. A. Koup et al., J. Virol. 68, 4650 (1994).
22. E. S. Rosenberg et al., Science 278, 1447 (1997).
23. B. Autran, F. Hadida, G. Haas, Curr. Opin. Immunol. 8, 546 (1996).
24. J. Levy et al., Blood 92, 3105 (1998).
25. M. Dalod et al., J. Infect. Dis. 178, 61 (1998).
26. G. S. Ogg et al., J. Virol. 73, 797 (1999).
27. G. Carcelain, P. Debré, B. Autran, Curr. Opin. Immunol. 13, 483 (2001).
28. E. S. Rosenberg et al., Nature 407, 523 (2000).
29. B. Autran, G. Carcelain, Science 290, 946 (2000).
30. R. C. Desrosiers, Nature Med. 10, 221 (2004).
31. Z. Hel et al., Nature Med. 6, 1140 (2003).
32. R. R. MacGregor et al., J. Infect. Dis. 178, 92 (1998).
33. X. Jin et al., J. Virol. 76, 2206 (2002).
34. R. Tubiana et al., Abstract 61, 10th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 10 to 14 February 2003.
35. We thank C. Katlama and the members of Objectif Recherche Vaccin Sida for their shared interest in the field of therapeutic vaccines; Fondation Bettencourt-Scueller, Agence Nationale de Recherche, and INSERM for their support; and J. A. Cahn for rewriting the manuscript.